These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6236244)

  • 1. Peripheral serotonergic receptor sensitivity in depressive illness.
    Wood K; Swade C; Abou-Saleh M; Coppen A
    J Affect Disord; 1984 Aug; 7(1):59-65. PubMed ID: 6236244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
    Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
    Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet and lymphocyte free intracellular calcium in affective disorders.
    Eckert A; Gann H; Riemann D; Aldenhoff J; Müller WE
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(5):235-9. PubMed ID: 8172937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral serotoninergic receptor sensitivity in senile dementia of the Alzheimer type.
    Thomas DR; Jones E; Warner N; Harris B; Williams P; Bentley P
    Biol Psychiatry; 1988 Jan; 23(2):136-40. PubMed ID: 3334883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of platelet 5-HT2 receptor indices to major depressive disorder, personality traits, and suicidal behavior.
    McBride PA; Brown RP; DeMeo M; Keilp J; Mieczkowski T; Mann JJ
    Biol Psychiatry; 1994 Mar; 35(5):295-308. PubMed ID: 8011798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet serotonin markers and depressive symptomatology.
    Sheline YI; Bardgett ME; Jackson JL; Newcomer JW; Csernansky JG
    Biol Psychiatry; 1995 Apr; 37(7):442-7. PubMed ID: 7786957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
    Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
    Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-HT2-selective agonists on cat platelet aggregation.
    Seggel MR; Qureshi GD; Glennon RA
    Life Sci; 1987 Aug; 41(9):1077-81. PubMed ID: 3613863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in platelet aggregatory responses to collagen and 5-hydroxytryptamine in depressed, schizophrenic and manic patients.
    McAdams C; Leonard BE
    Int Clin Psychopharmacol; 1992 Nov; 7(2):81-5. PubMed ID: 1487625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine and platelet aggregation.
    De Clerck FF; Herman AG
    Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rat platelet serotonin receptors with tryptamine agonists and the antagonists: ketanserin and SCH 23390.
    Killam AL; Cohen ML
    Thromb Res; 1991 Nov; 64(3):331-40. PubMed ID: 1805448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for functional 5-HT2 receptor sites on human blood platelets.
    De Clerck F; Xhonneux B; Leysen J; Janssen PA
    Biochem Pharmacol; 1984 Sep; 33(17):2807-11. PubMed ID: 6466388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of platelet serotonin receptors of patients with endogenous depression before and after treatment with antidepressive agents].
    Katasonov AB; Beliaev BS; Brusov OS; Zlobina GP; Faktor MI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):75-8. PubMed ID: 2633575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic dysfunction in depression.
    Meltzer H
    Br J Psychiatry Suppl; 1989 Dec; (8):25-31. PubMed ID: 2692637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of binding indices and physiological responsiveness of the 5-HT2 receptor on human platelets.
    McBride PA; Mann JJ; Polley MJ; Wiley AJ; Sweeney JA
    Life Sci; 1987 May; 40(18):1799-809. PubMed ID: 3573979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent supersensitivity of platelet 5-HT receptors in lithium-treated patients.
    Wood K; Swade C; Abou-Saleh MT; Coppen A
    J Affect Disord; 1985; 8(1):69-72. PubMed ID: 3156913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does platelet serotonin receptor supersensitivity accompany endogenous depression?
    Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Factor MI; Lideman RR
    Biol Psychiatry; 1989 Feb; 25(4):375-81. PubMed ID: 2930807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.